Related Experiment Videos
Opioid receptors and their ligands
Anna Janecka1, Jakub Fichna, Tomasz Janecki
1Department of Medicinal Chemistry, Medical University of Lodz, Lodz, Poland. ajanecka@zdn.am.lodz.pl
Current Topics in Medicinal Chemistry
|February 3, 2004
Summary
This review explores 25 years of opioid research, detailing brain-derived, milk protein-derived, and amphibian-derived opioids. It focuses on structure-activity relationships for potent and selective opioid receptor ligands.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Neuroscience
Background:
- Opioids are a class of compounds with significant physiological effects.
- Research over 25 years has expanded the understanding of opioid diversity and mechanisms.
- Opioid peptides are found in various biological sources, including the brain, milk, and amphibian toxins.
Purpose of the Study:
- To provide a historical overview of opioid research spanning approximately 25 years.
- To describe different classes of opioids, including typical, atypical, and amphibian-derived.
- To focus on structure-activity relationships of peptide ligands for micro, delta, and kappa opioid receptors.
Main Methods:
- Literature review of approximately 25 years of opioid research.
- Analysis of structure-activity relationships for peptide ligands.
- Discussion of chemical modifications for developing opioid receptor agonists and antagonists.
Main Results:
- Description of "typical" opioid peptides from the brain.
- Identification of "atypical" opioids within milk protein and hemoglobin sequences.
- Characterization of highly potent and selective opioids from amphibian sources.
- Detailed structure-activity relationship studies for micro, delta, and kappa opioid receptors.
- Discussion of chemical modifications yielding selective agonists and antagonists.
Conclusions:
- Significant advancements have been made in understanding opioid peptide diversity and function.
- Structure-activity relationship studies are crucial for developing selective opioid receptor modulators.
- Chemical modifications offer a pathway to potent and selective opioid agonists and antagonists for therapeutic development.